Expression of PLK1 is tightly regulated, peaking in M phase and sharply declining upon mitotic exited (Chiappa et al., 2022). In this study, we employed two PLK1-specific inhibitors, GSK461364 and ...

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to ...

Russia announced that it had developed an mRNA vaccine for cancer patients. The vaccine will be available from early 2025 and will be distributed for free. The vaccine will cost the Russian government ...

Russia has developed a groundbreaking mRNA cancer vaccine, set for public release in 2025. The vaccine, which will be distributed free of charge, has shown promising results in pre-clinical trials, ...

In a significant medical breakthrough, Russia has reportedly developed an mRNA vaccine against cancer, which will be made available to patients free of cost by 2025. The announcement was made by ...

Russia has announced the development of a pioneering mRNA vaccine against cancer, promising free access to patients by early 2025. Russia has developed an mRNA-based vaccine targeting cancer ...

Russia this week claimed it has developed its own mRNA-based vaccine to treat cancer, which will be available for free to patients from early 2025.(Pixabay) Russia this week claimed it has ...

Russian news agency claims the country has developed an mRNA vaccine against cancer. It is set to be available free of charge to patients by 2025. Listen to Story The vaccine was developed in ...

Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the one of the biggest problems with boosters. Immune imprinting, also known as original antigenic sin ...

Notably, HIF-1α and HIF-2α both increased in expression when VHL was inactivated initially ... MDM2 inhibitors enhance the transcription of MDM2 mRNA, resulting in elevated MDM2 protein levels. The ...

Penn Engineers have modified lipid nanoparticles (LNPs)—the revolutionary technology behind the COVID-19 mRNA vaccines—to not only cross the blood-brain barrier (BBB) but also to target ...

Engineers have modified lipid nanoparticles (LNPs) -- the revolutionary technology behind the COVID-19 mRNA vaccines -- to not only cross the blood-brain barrier (BBB) but also to target specific ...